IFNB1 and breast cancer: To the best of our knowledge, this is the first demonstration of the efficacy of IFNβ gene transfected stem cell therapy on breast carcinomas, proposing that IFNβ-hUCMSCs is a potential therapeutic agent for breast cancer.